Sex‐specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors
The FASEB Journal · 2024
DOI: 10.1096/fj.202402354r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Khyati Girdhar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Boston College, Chestnut Hill, Massachusetts, USA. Hauptthemen laut MEDLINE: Cytokines, Diabetes Mellitus, Type 1, Chemokines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JDRF Wallenberg Foundation, Östgöta Brandstodsbolag, ALF grants from Region Östergötland and Linköping University, Sweden.
Abstract (Originalsprache)
Numerous studies have reported altered cytokine levels in type 1 diabetes (T1D) patients, yet findings remain inconsistent. In this pilot study, we tested the hypothesis that circulating immune markers exhibit sex‐based differences in T1D, both prior to and after disease onset. We analyzed 47–48 cytokine, chemokine, and growth factor levels in two cohorts. To assess post‐disease differences, we analyzed serum samples from 25 controls and 25 T1D patients. To examine pre‐disease progression, we utilized samples from 21 control children and 16 T1D progressors, collected at age 5 years before disease onset. Across all T1D patients and controls, only macrophage colony‐stimulating factor and interleukin (IL)‐6 showed significant differences. However, we identified notable alterations when comparing sex‐age‐matched controls and T1D samples. Female T1D patients exhibited lower levels of inflammatory cytokines (tumor necrosis factor‐α, IL‐6, IL‐1a), Th2 cytokines (IL‐4, IL‐13), and chemokines (macrophage inflammatory protein (MIP)‐1α, regulated upon activation, normal T cell expressed and secreted, MIP‐3) compared to female controls, differences that were not observed in males. Notably, IL‐22 was lower in female T1D patients compared to female controls, whereas it was higher in male T1D patients compared to male controls. Male T1D patients showed elevated levels of growth factors (epidermal growth factor, platelet‐derived growth factor‐AB/BB) compared to male controls. In T1D progressors, growth‐regulated alpha was lower compared to controls in both sexes. Multiple regression analysis further revealed associations between cytokine levels and factors such as age, BMI, and breastfeeding duration. Overall, our findings serve as a proof of concept, highlighting the importance of sex‐specific differences in T1D pathogenesis. However, follow‐up studies with larger sample sizes are needed to validate and generalize these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Department, Boston College, Chestnut Hill, Massachusetts, USA.
- Department of Pathology, Immunology and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, USA.
- Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, USA.
- Division of Pediatrics, Department of Biomedical and Clinical Sciences, Crown Princess Victoria Children's Hospital, Linköping University, Linköping, Sweden.
ORCID-Profile: Khyati Girdhar, Keiichiro Mine, Jeffrey M DaCosta, Mark A Atkinson, Johnny Ludvigsson, Emrah Altindis
Förderung
- JDRF Wallenberg Foundation
- Östgöta Brandstodsbolag
- ALF grants from Region Östergötland and Linköping University, Sweden
- NIAID NIH HHS
- Diabetes Research Connection (DRC)
- Joanna Cocozza Foundation
- Medical Research Council of Southeast Sweden
- Swedish Council for Working Life and Social Research
Zitieren
APA
Girdhar, K., Mine, K., DaCosta, J. M., Atkinson, M. A., Ludvigsson, J., & Altindis, E. (2024). Sex‐specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors. The FASEB Journal. https://doi.org/10.1096/fj.202402354r
Vancouver
Girdhar K, Mine K, DaCosta JM, Atkinson MA, Ludvigsson J, Altindis E. Sex‐specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors. The FASEB Journal. 2024. doi:10.1096/fj.202402354r
BibTeX
@article{Girdhar2024,
author = {Girdhar, Khyati and Mine, Keiichiro and DaCosta, Jeffrey M and Atkinson, Mark A and Ludvigsson, Johnny and Altindis, Emrah},
title = {Sex‐specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202402354r}
}
EUVIMED